G Zbinden, R A Moe. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adrenergic alpha-Antagonists/therapeutic useAdrenergic beta-Antagonists/therapeutic useAmides/therapeutic useAnimalsAntihypertensive Agents/therapeutic useDogsFemaleGlucose/therapeutic useHeart Diseases/chemically inducedHeart Diseases/drug therapyImines/therapeutic useIsoproterenolLactates/therapeutic useMaleMiceMonoamine Oxidase Inhibitors/therapeutic useNecrosis/chemically inducedNecrosis/drug therapyPotassium Chloride/therapeutic usePyruvates/therapeutic useRatsReserpine/therapeutic useSulfones/therapeutic useThiouracil/therapeutic useToluene/therapeutic useTosyl Compounds/therapeutic useTranquilizing Agents/therapeutic useVasodilator Agents/therapeutic use
Substances: See more » Adrenergic alpha-AntagonistsAdrenergic beta-AntagonistsAmidesAntihypertensive AgentsIminesLactatesMonoamine Oxidase InhibitorsPyruvatesSulfonesTosyl CompoundsTranquilizing AgentsVasodilator AgentsTolueneThiouracilPotassium ChlorideReserpineGlucoseIsoproterenol
Year: 1969 PMID: 4400975 DOI: 10.1111/j.1749-6632.1969.tb16736.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691